Healthcare Revenue Cycle Management, ICD-10, Claims Reimbursement, Medicare, Medicaid

Prescription drug spending

Healthcare Spending Growth Slows, Increasing 3.9% in 2017

December 6, 2018 - Healthcare spending grew at a rate of 3.9 percent in 2017, slowing to rates observed during the 2008 to 2013 period, CMS actuaries recently reported. The analysis from the Office of the Actuary at CMS, published by Health Affairs, showed that healthcare spending growth continues to slow. Growth slowed for the second consecutive year after healthcare spending accelerated 4.8 percent in...


More Articles

HHS to Implement 340B Drug Price Ceiling, Penalties in Jan 2019

by Jacqueline LaPointe

After several delays, HHS will implement drug price ceilings and civil monetary penalties for manufacturers under the 340B Drug Pricing Program in 2019, according to a final rule from the HHS agency, Health Resources and Services...

HRSA Proposes Earlier Start Date for 340B Price Transparency Rule

by Jacqueline LaPointe

HHS plans to move forward the implementation date of a long-delayed 340B price transparency rule that will stop drug manufacturers from overcharging hospitals for drugs purchased under the drug discount program. In a recent notice of...

Would the IPI Model Reduce Medicare Reimbursement for Providers?

by Jacqueline LaPointe

Physicians and hospitals would not see Medicare reimbursement drop under the proposed International Pricing Index (IPI) model, the former Senior Advisor to the Secretary for Drug Pricing Reform recently assured providers. “The model...

CMS to Extend Healthcare Price Transparency to Prescription Drugs

by Jacqueline LaPointe

CMS is attempting to extend healthcare price transparency to prescription drugs. According to a recently proposed rule, drug manufacturers may have to start including the list price for the medications they advertise on television. As...

Steady, Moderate Growth for Healthcare Prices and Spending in 2018

by Jacqueline LaPointe

Healthcare prices and spending are seeing steady, but moderate growth, the Altarum Center for Value in Health Care recently reported. Healthcare prices increased just two percent in the second quarter of 2018, bringing healthcare price...

Hospital Markups Drive Prescription Drug Spending, PhRMA Says

by Jacqueline LaPointe

Prescription drug spending is rising because approximately 83 percent of hospitals charge patients and payers more than double the acquisition cost for medications, according to a recent analysis by the Moran Company for the Pharmaceutical...

Hospitals Create Drug Company to Combat Drug Shortages, Prices

by Jacqueline LaPointe

Seven health systems are stepping up to the plate to tackle two of the healthcare industry’s most pressing challenges: drug shortages and rising prescription drug rates. Catholic Health Initiatives, HCA Healthcare, Intermountain...

Prescription Drug Rate Growth to Slow in 2019, Increasing 4.92%

by Jacqueline LaPointe

Hospitals and health systems should anticipate prescription drug rates to increase by 4.92 percent in 2019, researchers from the healthcare improvement company Vizient recently estimated. Prescription drug rates for hospitals and health...

340B Hospitals Provided Similar Charity, More Uncompensated Care

by Jacqueline LaPointe

The debate over whether 340B hospitals truly use discounted prescription drug rates to improve care for vulnerable, low-income patients goes on with a new Government Accountability Office (GAO) report. GAO found that the median amount of...

Target Prices to Control Prescription Drug Spending, AHA Advises

by Jacqueline LaPointe

With prices, not utilization, driving prescription drug spending at hospitals and health systems, the American Hospital Association (AHA) recently called on policymakers to focus on controlling costs via average sales price (ASP)...

Court Rejects AHA’s Attempt to Block 340B Hospital Payment Cuts

by Jacqueline LaPointe

A federal appellate court recently tossed the American Hospital Association’s (AHA) lawsuit against HHS, which attempted to block $1.6 billion in 340B hospital payment cuts. Three judges on the US Court of Appeals for the District...

Hospitals to See More 340B Drug Pricing Program Oversight, Azar Says

by Jacqueline LaPointe

According to HHS Secretary Alex Azar, hospitals should expect greater transparency and oversight of the 340B Drug Pricing Program to track how the program’s benefits are used to improve care for low-income and vulnerable...

How Part B Drug Changes Could Impact Provider Reimbursement

by Jacqueline LaPointe

Healthcare industry experts are warning the Trump Administration that its proposal to transfer some drugs covered by Medicare Part B to Part D would have a negative impact on provider reimbursement and care quality. In the Trump...

Oncologist Org Fights Medicare Reimbursement Cut to Cancer Drugs

by Jacqueline LaPointe

A group representing over 5,000 independent, community-based oncologists is suing HHS over the implementation of a two percent sequester cut to Medicare reimbursement for Part B cancer drugs. The Community Oncology Alliance (COA) is...

Shifting Vaccinations to the Pharmacy Lowers Healthcare Costs

by Jacqueline LaPointe

Pharmacies can administer a wide range of vaccines to patients at significantly lower healthcare costs than physician practices and other medical settings, a new report from the Pacific Research Institute found. The literature review...

Pres Trump Eyes 340B Drug Reforms to Lower Prescription Drug Costs

by Jacqueline LaPointe

The 340B Drug Pricing Program could face some changes under the Trump Administration’s latest plan to reduce prescription drug costs. The United States had the highest per-capita prescription drug spending in 2015, the President...

X

Join 30,000 of your peers and get free access to all webcasts and exclusive content

Sign up for our free newsletter:

Our privacy policy


no, thanks

Continue to site...